Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008Chezi Ganzel, Judith Manola, Dan Douer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
The New England Journal of Medicine|September 25, 2009
Anthracycline dose intensification in acute myeloid leukemiaHugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Blood Advances|April 8, 2025
Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy InductionMeira Yisraeli Salman, Alexander R Terry, Andriy Derkach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxisRonit Elhasid, Myriam Ben Arush, Irena Zaidman, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008Chezi Ganzel, Judith Manola, Dan Douer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
The New England Journal of Medicine|September 25, 2009
Anthracycline dose intensification in acute myeloid leukemiaHugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Blood Advances|April 8, 2025
Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy InductionMeira Yisraeli Salman, Alexander R Terry, Andriy Derkach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxisRonit Elhasid, Myriam Ben Arush, Irena Zaidman, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Pageof 28